Benzinga's Top #PreMarket Losers

NPS Pharmaceuticals NPSP fell 10.70% to $29.20 in pre-market trading. The FDA has voted 8-5 in favor of NPS Pharmaceuticals' Natpara. Achillion Pharmaceuticals ACHN shares slipped 3.28% to $11.78 in pre-market trading after falling 3.87% on Friday. Cree CREE shares dipped 2.75% to $41.50 in pre-market trading. Goldman Sachs downgraded from Buy to Neutral and lowered the target price from $60 to $48. Symantec SYMC dropped 2.16% to $24.00 in pre-market trading. Analysts at RBC Capital downgraded Symantec from Outperform to Sector Perform. Gilead Sciences GILD shares fell 1.41% to $102.20 in pre-market trading after the company reported that it has signed licensing agreements with seven India-based generic pharmaceutical manufacturers to expand access to its hepatitis C treatments in developing countries.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!